Regarding targeted therapy, the co-delivery of GEM and cetuximab via magnetic-albumin NPs permits not only the triple therapy by magnetic-targeted thermo-chemotherapy but also the targeting of both stromal and tumor cells. Here, ALB is linked to neoplasm.